Advanced Magnetics raises $32 million

MRI contrast developer Advanced Magnetics said it issued 1.2 million shares of common stock, raising $31.7 million after deducting fees and expenses.

The proceeds from the transaction will be used to fund clinical development programs, including continued development of the company's ferumoxytol as an iron replacement therapeutic, and for general working capital purposes, the company said.

By staff writers
March 8, 2006

Related Reading

Advanced Magnetics to defend Cytogen suit, January 30, 2006

Cytogen sues Advanced Magnetics, January 26, 2006

FDA requests Combidex information, March 24, 2005

U.S. panel rejects Advanced Magnetics imaging agent, March 4, 2005

Combidex gets FDA review date, February 1, 2005

Copyright © 2006

Page 1 of 607
Next Page